More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
The licence covers Actimed’s existing patents, its proprietary know-how and any future related patents, giving Mankind full control to advance the products under its own brands
Anil Gupta has been appointed as the Senior Vice President, and Sanjay Singhania has taken charge as the Vice President of PHDCCI
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
The company has posted net profit of Rs. 1,986.43 crores for the Financial Year ended March 31, 2025
The camp, operational daily from 12 PM to 4 PM, offers free health check-ups, blood pressure monitoring
Q3 FY25 revenue up 24% to Rs 3,230 crore
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Subscribe To Our Newsletter & Stay Updated
